Virginia Gillespie

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Combination Therapy

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Induced Pluripotent Stem Cells

Top Venues

Nature communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Carolina Rosselot, Yansui Li, Peng Wang, Alexandra Alvarsson, Kara Beliard, Geming Lu, Randy Kang, Rosemary Li, Hongtao Liu, Virginia Gillespie, Nikolaos Tzavaras, Kunal Kumar, Robert J DeVita, Andrew F Stewart, Sarah A Stanley, Adolfo Garcia-Ocaña
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system. Science translational medicine 16 (755) (2024)
Raveen Rathnasinghe, Sonia Jangra, Chengjin Ye, Anastasija Cupic, Gagandeep Singh, Carles Martínez-Romero, Lubbertus C F Mulder, Thomas Kehrer, Soner Yildiz, Angela Choi, Stephen T Yeung, Ignacio Mena, Virginia Gillespie, Jana De Vrieze, Sadaf Aslam, Daniel Stadlbauer, David A Meekins, Chester D McDowell, Velmurugan Balaraman, Michael J Corley, Juergen A Richt, Bruno G De Geest, Lisa Miorin, null null, Florian Krammer, Luis Martinez-Sobrido, Viviana Simon, Adolfo García-Sastre, Michael Schotsaert
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera. Nature communications 13 (1) (2022)